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Abstract
Introduction:  Chronic  rhinosinusitis  with  nasal  polyps  is  a  multifactorial  disease  entity  with  an
unclear pathogenesis.  Contradictory  data  exist  in  the  literature  on  the  potential  implication  of
viral elements  in  adult  patients  with  chronic  rhinosinusitis.
Objective:  To  compare  the  prevalence  of  human  herpes  viruses  (1--6)  and  Human  Papilloma
Virus in  adult  patients  with  chronic  rhinosinusitis  with  nasal  polyps  and  healthy  controls.
Methods: Viral  DNA  presence  was  evaluated  by  real-time  polymerase  chain  reaction  application
to nasal  polyps  specimens  from  91  chronic  rhinosinusitis  with  nasal  polyps  patients  and  nasal
turbinate mucosa  from  38  healthy  controls.
Results:  Epstein--Barr  virus  positivity  was  higher  in  nasal  polyps  (24/91;  26.4%)  versus  controls
(4/38; 10.5%),  but  the  difference  did  not  reach  signiﬁcance  (p  =  0.06).  Human  herpes  virus-6
positivity  was  lower  in  nasal  polyps  (13/91;  14.29%)  versus  controls  (10/38;  26.32%,  p  =  0.13).
In chronic  rhinosinusitis  with  nasal  polyps  group,  1  sample  was  herpes  simplex  virus-1-positive
(1/91;  1.1%),  and  another  was  cytomegalovirus-positive  (1/91;  1.1%),  versus  none  in  controls.  No
sample was  positive  for  herpes  simplex  virus-2,  varicella-zoster  virus,  high-risk-human  papilloma
viruses (16,  18,  31,  33,  35,  39,  45,  51,  52,  56,  58,  59)  and  low-risk-human  papilloma  viruses  (6,
11).
Conclusion:  Differences  in  Epstein--Barr  virus  and  human  herpes  virus-6  positivity  among
patients with  chronic  rhinosinusitis  with  nasal  polyps  and  healthy  controls  are  not  statistically
signiﬁcant,  weakening  the  likelihood  of  their  implication  in  chronic  rhinosinusitis  with  nasal
polyps pathogenesis.
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Herpesvírus  e  vírus  do  papiloma  humano  na  polipose  nasal  e  controles
Resumo
Introduc¸ão:  A  rinossinusite  crônica  com  pólipos  é  uma  doenc¸a  multifatorial  de  etiopatogênese
ainda não  deﬁnida.  Existem  dados  contraditórios  na  literatura  sobre  a  implicac¸ão  potencial  de
elementos  virais  na  etiologia  de  pólipos  nasossinusais.
Objetivo:  Comparar  a  prevalência  de  herpes  vírus  humanos  (1--6)  e  papiloma  vírus  humano  em
pacientes  adultos  com  rinossinusite  crônica  com  pólipos  nasais  (CRwNP)  e  controles  saudáveis.
Método: A  presenc¸a  de  DNA  viral  foi  avaliada  por  PCR  em  tempo  real,  em  amostras  de  pólipos
nasais de  91  pacientes  com  CRwNP  e  na  mucosa  das  conchas  nasais  de  38  controles  saudáveis.
Resultados:  A  positividade  do  EBV  foi  maior  nos  pólipos  nasais  (24/91;  26,4%)  do  que  nos
controles (4/38;  10,5%),  mas  a  diferenc¸a  não  foi  signiﬁcante  (p  =  0,06).  O  HHV-6  apresentou
positividade  menor  nos  pólipos  nasais  (13/91;  14,29%)  do  que  os  controles  (10/38;  26,32%),
(p =  0,13).  No  grupo  CRwNP,  uma  amostra  foi  positiva  para  o  vírus  herpes  simples  (HSV-1)  (1/91;
1,1%), e  uma  para  citomegalovírus  (CMV)  (1/91;  1,1%);  e  nenhuma  amostra  foi  positiva  no  grupo
controle.  Não  houve  amostra  positiva  para  HSV-2,  VZV,  HR-HPV  (16,18,  31,  33,  35,  39,  45,  51,
52, 56,  58,  59)  e  LR-HPV  (6,11).
Conclusão:  Diferenc¸as  de  positividade  do  EBV  e  HHV-6  entre  pacientes  com  CRwNP  e  con-
troles saudáveis  não  são  estatisticamente  signiﬁcantes,  enfraquecendo  a  probabilidade  de  sua
implicac¸ão na  patogênese  da  CRwNP.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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Chronic  rhinosinusitis  with  nasal  polyps  (CRSwNP)  is  a  sub-
division  of  idiopathic  chronic  rhinosinusitis  (CRS).1 It  is  a
clinical  syndrome  characterized  by  persistent  symptomatic
inﬂammation  of  the  nasal  and  paranasal  sinuses  mucosa.1
The  etiopathogenesis  of  CRSwNP  is  mainly  attributed  to  a
dysfunctional  host--environment  interaction.2 Even  though
the  identiﬁcation  of  exogenous  agents  driving  the  secondary
inﬂammatory  mechanisms  has  been  a  ﬁeld  of  extensive
research,  the  potential  involvement  of  viral  infection  is  rel-
atively  unstudied.1
Herpes  simplex  virus-1  (HSV-1),  herpes  simplex  virus-
2  (HSV-2),  varicella-zoster  virus  (VZV),  cytomegalovirus
(CMV),  Epstein--Barr  virus  (EBV),  and  human  herpes  virus-
6  (HHV-6),  along  with  human  papilloma  viruses  (HPV),  are
DNA  viruses  that  have  the  capacity  to  incorporate  into  host
DNA,  to  establish  lifelong  latent  infections  in  the  upper
respiratory  mucosa,  and  to  reactivate  in  immunocompro-
mised  conditions.3--6 Only  a  few  studies7--17 have  investigated
their  potential  role  in  CRSwNP,  while  their  results  are  con-
troversial.  Furthermore,  the  highly  sensitive  quantitative
real-time  polymerase  chain  reaction  (PCR)  technique  has
been  used  for  detection  of  these  viruses  in  CRSwNP  by  only
two  studies  so  far.11,17
The  aims  of  the  present  study  were  to  evaluate  and
compare  the  prevalence  of  HHV,  high-risk  HPV  types  (HR-
HPV;  subtypes  16,  18,  31,  33,  35,  39,  45,  51,  52,  56,
58,  59),  and  low-risk  HPV  types  (LR-HPV;  subtypes  6,
11)  in  nasal  tissue  samples  of  patients  with  CRSwNP
and  healthy  controls  by  employing  the  highly  sensitive
quantitative  PCR  technique,  and  to  review  the  related
literature.
S
b
aethods
his  was  a  cross-sectional  contemporary  cohort  study,  which
as  conducted  prospectively,  from  January  of  2009  to  Jan-
ary  of  2013,  on  adult  patients  with  CRSwNP  undergoing
unctional  endoscopic  sinus  surgery  (FESS).  CRSwNP  diag-
osis  was  made  according  to  the  criteria  of  the  European
osition  Paper  on  Rhinosinusitis  and  Nasal  Polyps  (EPOS).1
he  control  group  consisted  of  healthy  adult  patients  with
asal  septal  deviation  undergoing  septoplasty  without  CRS
ccording  to  EPOS  criteria.1 Pediatric  subjects,  as  well  as
atients  with  asthma,  cystic  ﬁbrosis,  primary  ciliary  dysk-
nesia,  allergic  fungal  sinusitis,  allergic  rhinitis,  inverted
apilloma,  and  HIV  seropositivity  were  excluded  from  the
tudy.  Subjects  in  both  groups  who  had  had  an  upper  respi-
atory  tract  infection  within  two  weeks  before  surgery,  and
hose  who  had  taken  any  nasal  or  systemic  steroids  within
he  last  month  prior  to  surgery  were  excluded  from  the
tudy.
In  CRSwNP  patients,  nasal  polyp  specimens  were
btained  from  the  paranasal  sinuses  during  FESS,  while  in
he  control  group  tissue  biopsies  from  the  inferior  turbinate
ucosa  were  taken  during  septorhinoplasty.  Nasal  polyps
nd  nasal  tissues  extracted  during  surgery  were  immediately
ransferred  in  sterile  dry  containers  and  shipped  to  the  lab-
ratory.  By  use  of  a  surgical  knife,  the  tissues  were  cut  in
alf,  and  several  pieces  (2--4  mm)  were  taken  from  the  deep
issue  and  divided  into  three  parts:  for  conventional  culture,
or  molecular  techniques  and  for  storage  at  −80 ◦C.For  each  patient,  the  tissue  pieces  were  inoculated  on
abouraud  agar  at  30 ◦C  for  10  days  and  then  on  5%  sheep
lood  Columbia  agar  incubated  in  a  5%  CO2 atmosphere
nd  an  anaerobic  atmosphere  for  2  days.  Gram  staining
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Table  1  Epidemiological  data  on  sex,  age,  and  type  of
surgery  (primary  or  revision)  for  chronic  rhinosinusitis  with
nasal polyps  (CRSwNP)  and  control  groups.
CRSwNP  group  Control  group
Total 91  38
Male (%) 63  (69.2%) 22  (57.9%)
Female  (%) 28  (30.8%) 16  (42.1%)
Mean  age  (range) 53  (19--77) 43  (18--54)
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DPrimary  surgery  (%)  65  (71.4%)  N/A
Revision  surgery  (%)  26  (28.6%)  N/A
as  performed  on  all  specimens  in  order  to  evaluate  the
resence  of  leukocytes  and  microbial  ﬂora.
Samples  of  tissue  from  each  patient  were  chosen  for
NA  extraction  using  commercial  kits  (Invitrogen)  accord-
ng  to  the  manufacturer’s  instructions.  The  efﬁciency  of  DNA
xtraction  and  the  possible  presence  of  inhibitors  in  the  sam-
le  were  conﬁrmed  by  the  detection  of  the  2-globin  gene
sing  the  primers  RS42  (5′-GCTCACTCAGTG  TGGCAAAG-3′)
nd  Km  (5′-GGTTGGCCAATCTACTCCCAGG-3′).
The  extracted  DNA  specimens  were  submitted  to  quan-
itative  real-time  PCR  (Applied  Biosystems  7500  Fast
eal-Time  PCR  System)  by  using  commercially  available
ssays  according  to  the  manufacturer’s  instructions:  HSV1  Q-
CR  Alert  AmpliMIX,  HSV2  Q-PCR  Alert  AmpliMIX,  VZV  Q-PCR
lert  AmpliMIX,  EBV  Q-PCR  Alert  AmpliMIX,  Q-CMV  Real  Time
omplete,  HHV-6  Q-PCR  Alert  AmpliMIX  (Nanogen  Advanced
iagnostics  S.r.L),  the  HPV  High  Risk  Screen  Real  Time  PCR
Sacace  Biotechnologies)  and  HPV  6/11  Real-TM  Real  Time
CR  kit  (Sacace  Biotechnologies).
All  data,  including  patients’  demographic  information
age,  gender,  history)  were  placed  in  a  database.  For  sta-
istical  analysis,  Fisher’s  exact  test  was  used.  Data  analysis
as  performed  with  SPSS  v.  20  software  (IBM,  Chicago,  IL,
nited  States).  p-values  <0.05  were  considered  as  statisti-
ally  signiﬁcant.
The  samples  were  analyzed  at  the  Department  of  Microbi-
logy,  Medical  School,  University  of  Thessaly.  The  study  was
pproved  by  the  institutional  review  board  (approval  pro-
ocol  No.  10/28-11-2007).  A  written  informed  consent  was
btained  from  all  patients  and  control  subjects.
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Table  2  Rates  of  HSV-1,  HSV-2,  VZV,  CMV,  EBV,  HHV-6,  and  HPV  (H
polyps (CRSwNP)  and  control  groups.
CRSwNP  (n  =  91)  
Positive  --  n  (%)  
HSV1  1  (1.1%)  
HSV2 0  (0%)  
VZV 0  (0%)  
EBV 24  (26.4%)  
CMV 1  (1.1%)  
HHV-6 13  (14.29%)  
HR-HPV 0  (0%)  
LR-HPV 0  (0%)  
NS, non-signiﬁcant; HSV-1, herpes simplex virus-1; HSV-2, herpes simpl
Epstein--Barr virus; HHV-6, human herpes virus-6; HPV, human papillom
a Fisher’s exact testIoannidis  D  et  al.
esults
here  were  129  white  subjects  enrolled  in  the  study.  The
asal  polyps  group  consisted  of  91  patients  (63  males;  mean
ge  53  years;  range  19--77  years)  while  the  control  group
onsisted  of  38  subjects  (22  males;  mean  age  43  years;  range
8--54  years).  Primary  surgery  was  performed  in  65  patients
nd  revision  surgery  in  26  patients  (epidemiological  data  are
ummarized  in  Table  1).
Conventional  cultures  showed  that  all  specimens  were
egative  for  fungi,  while  they  were  positive  for  Gram-
ositive  cocci  of  microbial  ﬂora,  including  Staphylococcus
ureus,  coagulase-negative  staphylococci,  and  viridans
treptococci.
DNA  extraction,  indicated  by  2-globin  gene  detection,
as  successful  in  all  the  samples.
EBV  positivity  was  higher  in  nasal  polyps  than  the  con-
rol  group  (polyps  group:  24/91;  26.4%  versus  control  group:
/38;  10.5%).  This  difference  did  not  reach  signiﬁcance
p  =  0.06).
HHV-6  positivity  was  lower  in  nasal  polyps  than  the
ontrol  group  (polyps  group:  13/91;  14.29%  versus  control
roup:  10/38;  26.32%).  This  difference  was  also  not  signiﬁ-
ant  (p  =  0.13).
One  nasal  polyp  sample  (1/91;  1.1%)  was  found  to  be  HSV-
 positive  and  one  sample  (1/91;  1.1%)  was  found  to  be  CMV
ositive.  All  control  group  samples  were  negative  for  the
SV-1  and  CMV.  These  differences  were  not  signiﬁcant.
In  nasal  polyps  group,  the  specimens  of  four  patients
ere  positive  for  both  EBV  and  HHV-6,  while  in  one  patient
hey  were  positive  for  both  EBV  and  CMV.  Simultaneous  pos-
tivity  in  EBV  and  HHV-6  was  also  noticed  in  two  subjects  of
he  control  group.
All  specimens  of  study  and  control  groups  were  nega-
ive  for  HSV2,  VZV,  HR-HPV,  and  LR-HPV  DNA  (results  are
ummarized  in  Table  2).
iscussionozak  et  al.7 were  the  ﬁrst  to  investigate  the  potential  role
f  EBV  in  the  etiology  of  nasal  polyps.  In  a pilot  study  on
ine  patients  with  CRSwNP  and  six  controls  using  in  situ
R-HPV  and  LR-HPV  types)  in  chronic  rhinosinusitis  with  nasal
Control  (n  =  38)  Signiﬁcancea
Positive  --  n  (%)
0  (0%)  NS
0  (0%)  NS
0  (0%)  NS
4  (10.5%)  NS
0  (0%)  NS
10  (26.32%)  NS
0  (0%)  NS
0  (0%)  NS
ex virus-2; VZV, varicellazoster virus; CMV, cytomegalovirus; EBV,
a viruses; HR-HPV, high-risk HPV; LR-HPV, low risk HPV.
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CHerpes  viruses  and  human  papilloma  virus  in  nasal  polyposis
hybridization  (ISH),  they  reported  that  EBV  DNA  was  absent
in  both  groups.  Similar  ﬁndings  with  ISH  were  published  by
Sham  et  al.8 in  2012,  in  30  CRSwNP  patients  and  32  con-
trols.  In  contrast,  Tao  et  al.9 were  the  ﬁrst  to  report  nasal
polyp  mucosa  as  one  of  the  sites  of  EBV  persistence.  They
studied  13  CRSwNP  patients  and,  by  using  Southern  blot
hybridazation  (SBH),  qualitative  PCR,  and  ISH,  found  EBV
positivity  in  15%,  69%,  and  85%,  respectively.  However,  no
controls  were  used  in  their  study.  Zaravinos  et  al.10 com-
pared  nasal  polyp  samples  of  23  patients  to  a  control  group
of  13  inferior  turbinate  specimens  from  patients  undergo-
ing  nasal  corrective  surgery,  by  using  qualitative  PCR.  They
found  EBV  positivity  in  35%  of  CRSwNP  patients  versus  0%  in
their  control  group,  demonstrating  a  signiﬁcant  correlation
between  EBV  presence  and  nasal  polyp  formation.  Recently,
Costa  et  al.11 were  the  ﬁrst  to  use  quantitative  PCR  in  35
patients  with  CRSwNP,  in  order  to  compare  the  occurrence
of  EBV  in  nasal  polyps  and  adjacent  inferior  turbinates  tis-
sue  samples.  They  found  that  EBV  positivity  tended  to  be
higher  in  CRSwNP,  suggesting  a  potential  causative  role  or
persistence  in  the  inﬂammatory  lymphoid  tissue,  but  this
difference  did  not  reach  signiﬁcance.  However,  the  main
limitation  of  their  study  was  the  lack  of  a  control  group  of
healthy  subjects.  The  present  results  are  supportive  to  those
published  by  Costa  et  al.,11 since  EBV  positivity  was  higher
in  CRSwNP  than  healthy  controls,  but  this  difference  did  not
reach  signiﬁcance  (p  =  0.06).
Regarding  HPV,  controversial  ﬁndings  have  also  been
reported.  Bradnsma  et  al.12 and  Gaffey  et  al.,13 by  using
SBH  and  ISH  respectively,  reported  zero  HPV  positivity  in
CRSwNP  patients.  Becker  et  al.14 and  Sham  et  al.,8 by  using
qualitative  PCR,  also  did  not  ﬁnd  any  HPV  positivity  in  both
CRSwNP  patients  and  controls.  In  2000,  Hoffman  et  al.15
reported  a  single  suspicious  HPV  positive  sample  in  a  group
of  33  nasal  polyp  patients  by  using  SBH  and  qualitative  PCR,
while  Zaravinos  et  al.,10 utilizing  qualitative  PCR  (GP5+/6+
non-type-speciﬁc  primers),  found  a  non  signiﬁcant  presence
of  HPV  in  CRSwNP  patients  (3/23,  13%)  compared  to  their
controls  (0/13  inferior  turbinates).
On  the  contrary,  Fei  Pei  et  al.,16 in  a  large-scale  Chinese
study,  used  qualitative  PCR  and  ﬂow-through  hybridization
as  well  as  gene  chip  technology  for  detection  of  low  risk-
HPV  (LR-HPV)  and  HR-HPV  in  204  CRSwNP  patients  and  36
healthy  controls  (middle  turbinate  mucosa).  They  reported
40.2%  HPV  positivity  in  CRSwNP  versus  0%  in  controls.  In  their
study,  13  HPV  genotypes  were  found  in  CRSwNP  samples  (LR-
HPV  subtypes:  11,  6,  34,  70,  44;  and  HR-HPVs  subtypes:  58,
52,  18,  16,  68,  53,  31,  33),  with  LR-HPV-11  the  most  preva-
lent  (45.28%).  The  present  study  did  not  conﬁrm  the  results
published  by  Fei  Pei  et  al.16 The  different  ﬁndings  could  be
attributed  to  differences  in  study  populations  (Asian  versus
white)  or  the  method  used  to  detect  HPV  infection  (qual-
itive  versus  quantitative  PCR).  Recently,  Rizzo  et  al.,17 in
a  white  population  of  20  CRSwNP  patients  and  ten  con-
trols,  used  quantitative  real  time  PCR  for  the  ﬁrst  time
with  HR-HPV  (subtypes:  16,  18,  31,  33,  35,  39,  45,  52,
53,  56,  58,  59,  66,  and  70)  and  LR-HPV  (subtypes:  6,  11).
No  HR-HPV  positivity  was  found  in  their  study.  Regarding
LR-HPV,  they  reported  a  50%  HPV-11  presence  in  the  sub-
group  of  ten  CRSwNP  patients  without  allergic  disease,  while
no  positive  samples  were  found  in  the  subgroup  of  ten
CRSwNP  patients  with  allergic  disease,  as  well  as  in  their
T
w
t controls  661
ontrol  group.  The  authors  suggested  that  clinical  parame-
ers,  such  allergy,  could  be  a  confounder  for  the  HPV  results
bserved.  Furthermore,  they  suggested  that  the  presence
f  HPV-11  might  be  a  prognostic  marker  in  the  follow-up
f  CRSwNP  without  allergic  disease,  since  they  noticed  that
he  ﬁve  HPV-11  positive  patients  presented  with  a  relaps-
ng  nasal  polyposis.17 In  the  present  study  quantitative  PCR
as  used  in  a  large  population  of  91  CRSwNP  patients  and
8  controls.  These  results  conﬁrm  those  published  by  Rizzo
t  al.17 regarding  the  absence  of  HR-HPV  in  both  patients  and
ontrols.  However,  this  study  did  not  conﬁrm  the  high  preva-
ence  of  LR-HPV-11  reported  in  their  study.  The  differences
etween  the  present  ﬁndings  may  be  attributed  to  the  dif-
erences  in  the  size  of  the  samples.  It  should  be  noted  that
his  study  did  not  ﬁnd  any  LR-HPV  positivity,  while  allergic
atients  were  excluded,  and  26  patients  underwent  revision
urgery.
Zaravinos  et  al.10 were  the  ﬁrst  to  investigate  HHV-6  pres-
nce  in  nasal  polyp  tissue.  By  using  qualitative  PCR,  they
ound  that  HHV-6  DNA  was  absent  in  both  nasal  polyps  and
nferior  turbinate  samples  of  the  control  group.  However,
osta  et  al.11 used  quantitative  PCR  in  nasal  polyps  and
nferior  turbinate  samples  of  35  patients  with  CRSwNP,  and
ound  an  HHV-6  positivity  of  8%  in  nasal  polyps  and  35%  in
djacent  turbinate  mucosa.  This  difference  was  not  signiﬁ-
ant,  and  there  was  no  control  group  of  healthy  subjects  in
heir  study.  The  present  data  support  the  ﬁndings  of  Costa
t  al.,11 since  HHV-6  positivity  was  lower  in  nasal  polyps  than
nferior  turbinate  samples  of  the  control  group  (14.29%  ver-
us  26.32%  respectively),  while  this  difference  was  also  not
igniﬁcant.  It  is  probable  that  the  difference  between  the
resent  results  and  those  published  by  Zaravinos  et  al.10 may
e  due  to  the  higher  sensitivity  and  speciﬁcity  of  quantita-
ive  versus  qualitative  PCR.11
The  presence  of  HSV-1,  HSV-2,  VZV,  and  CMV  was  investi-
ated  by  Zaravinos  et  al.10 with  qualitative  PCR  and  by  Costa
t  al.11 with  quantitative  PCR.  Both  reported  similar  ﬁndings
two  positive  HSV-1  samples  and  one  CMV  sample  each,  while
o  HSV-2  or  VZV  presence  was  found)  in  line  with  the  present
ata.
The  main  weakness  of  this  study  is  that  there  was  a  dif-
erence  in  the  sample  size  of  the  CRSwNP  (n  =  91)  and  control
n  =  38)  groups.  These  sample  sizes  are  so  different  because,
ithin  the  study  period,  only  38  of  the  septoplasty  patients
ccepted  to  participate.  This  difference  in  sample  size  might
ave  inﬂuenced  the  results  and  may  explain  some  differ-
nces  with  the  results  already  reported  in  the  literature.
urthermore,  as  stated  above,  the  results  may  be  different
ith  those  already  published  due  to  the  different  methods
sed  to  detect  the  viruses  (ISH  versus  SBH  versus  qualita-
ive  PCR  versus  quantitative  PCR).  It  should  be  noticed  that
part  from  this  study,  only  Costa  et  al.11 have  used  quantita-
ive  PCR.  This  is  also  one  of  the  strengths  of  this  study,  since
uantitative  PCR  is  the  method  with  the  highest  sensitivity
nd  speciﬁcity.
onclusionhese  data  demonstrate  that  EBV  and  HHV-6  were  detected
ith  quantitative  PCR  in  nasal  polyps  specimens,  even
hough  with  no  signiﬁcance;  moreover,  this  study  showed
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hat  HR-HPV  and  LR-HPV  were  absent  in  nasal  polyps  and
ontrols.
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